The efficacy of azithromycin combined with seven types of Chinese medicine injections in the treatment of <i>Mycoplasma pneumoniae</i> pneumonia in children: a systematic review and Bayesian network meta-analysis.

ABSTRACT: Mycoplasma pneumoniae pneumonia (MPP) is the predominant community-acquired pneumonia (CAP) in children aged 5 years or older. In recent decades, the annual increase in drug resistance rates of macrolide antibiotics, particularly azithromycin (AZ), has led to complex clinical treatment strategies and substantial healthcare costs associated with MPP. Chinese medicine injections (CMIs), recognized as an effective supplementary therapy, are acknowledged by clinicians in China. It is necessary to explore the efficacy of azithromycin in combination with CMIs.

Methods

Randomized controlled trials (RCTs) evaluating azithromycin in combination with seven types of CMIs for MPP in children were identified based on inclusion criteria and assessed using the revised Cochrane risk of bias

SUBMITTER: Huang X 

PROVIDER: S-EPMC11484089 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature